Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Revenue of Mosgorlombard in the first half of the year increased 4.6 times

7/2/24 MGKL

MTS Live will launch its own clown theater

7/2/24 MTSS

Shareholders of Novoship approved dividends for 2023

7/2/24 NOMP

RusHydro awaits the decision of its major shareholder

7/1/24 HYDR

RusHydro shareholders failed to approve dividends for 2023 results

7/1/24 HYDR

Shareholders of Moscow confectionery factory Krasny Oktyabr approved dividends for 2023

7/1/24 KROT

Cosmos Hotel Group will increase its room stock 4.8 times

7/1/24 AFKS

Russneft withdraws from assets in Azerbaijan

7/1/24 RNFT

Shareholders of Udmurtneft approved dividends for 2023

7/1/24 UDMN

Shareholders of Novorossiysk Bakery Products Plant approved dividends for 2023

7/1/24 NKHP